DNA-encoded Library Market to Grow with a CAGR of 13.51% through 2030
Increasing
adoption of DNA-encoded libraries for identifying small molecule drug
candidates and advancements in automation and bioinformatics tools for drug
screening, is expected to drive the Global DNA-encoded Library
Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “DNA-encoded Library Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global DNA-encoded Library Market stood at USD 762.08 Million in 2024 and is
expected to reach USD 1632.26 Million by 2030 with a CAGR of 13.51% during the forecast
period. The Global
DNA-encoded Library (DEL) Market is advancing rapidly as pharmaceutical and
biotech companies seek more efficient methods for compound identification in
drug discovery. DEL technology offers an unparalleled ability to screen vast
chemical libraries, reducing the time and resources needed to discover
potential drug candidates. Increasing demand for novel therapeutics, especially
in challenging disease areas like oncology and neurodegenerative disorders, has
pushed research institutions and industry players to adopt DEL approaches. The
cost advantages over traditional high-throughput screening and the capacity to
explore diverse chemical spaces provide competitive benefits, driving
widespread interest in this technology. Efforts to improve DEL compatibility
with various target classes and biological systems further support its
adoption.
Recent
market trends reveal an expansion in service offerings, with providers
delivering end-to-end solutions from library design and synthesis to screening
and hit validation. There is a growing focus on miniaturization and automation
to enhance throughput and reduce reagent consumption. The development of
modular platforms that allow customization based on specific research needs is
also gaining traction. Industry players are leveraging partnerships to access
proprietary libraries and combine expertise, creating a more collaborative
ecosystem. Furthermore, advances in sequencing technologies and data analytics
are improving the accuracy and speed of decoding DNA tags, facilitating more
reliable identification of active compounds from complex mixtures.
Growth
opportunities in the DEL market lie in expanding applications beyond small
molecules, such as targeting protein-protein interactions and RNA molecules,
which have traditionally been difficult to drug. Increasing interest in rare
and neglected diseases offers avenues for DEL platforms to identify novel leads
where conventional methods have limited success. The convergence of DEL with
complementary technologies like fragment-based drug design and phenotypic
screening can open new frontiers in drug discovery. Emerging markets present
untapped potential as they develop infrastructure and invest in biotech
research. Expanding collaborations between academic institutions and industry
players can foster innovation and accelerate translation from discovery to
development. Continuous improvements in library diversity and encoding
techniques will also create new possibilities for addressing unmet medical
needs, positioning the DEL market for strong growth ahead.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global DNA-encoded Library Market”
The Global DNA-encoded
Library Market is segmented into product & service, therapeutic area,
application, end use, regional distribution, and company.
Based on the Application,
Hit Validation/Optimization emerged as the fastest growing segment in the Global
DNA-encoded Library Market during the forecast period. This is driven by the increasing need for
efficient identification and refinement of promising drug candidates early in
the drug discovery process. DEL technology enables researchers to rapidly
screen vast chemical spaces and identify “hits” potential molecules that bind
effectively to biological targets. However, the initial hits often require
extensive validation and optimization to improve their efficacy, selectivity,
and safety profiles before progressing to clinical development. Advancements in
computational tools and bioinformatics are enhancing the ability to analyze DEL
screening data, facilitating more precise hit validation and structure-activity
relationship studies. Pharmaceutical and biotech companies are investing
heavily in these optimization processes to reduce drug development timelines
and costs.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
DNA-encoded Library Market during
the forecast period. The rising prevalence of chronic diseases, including
cancer and metabolic disorders, has spurred demand for novel therapeutic
agents, making DEL technology crucial in accelerating the drug discovery
process. Biotechnology startups and established pharmaceutical companies in
Asia-Pacific are increasingly adopting DNA-encoded libraries to enhance their
screening capabilities and reduce the time and costs associated with
early-stage drug development. Collaborative efforts between academic
institutions and industry players are also increasing, fostering innovation and
facilitating the commercialization of DEL technologies. Enhanced infrastructure,
improved regulatory frameworks, and growing awareness about the benefits of DEL
further support the market’s rapid expansion. As a result, the Asia-Pacific
region is poised to outpace other global markets in terms of growth rate, reflecting
its evolving prominence in advanced drug discovery methodologies and
technologies.
Major
companies operating in Global DNA-encoded Library Market are:
- Merck
KGaA
- GenScript
Biotech Corporation
- Pharmaron
Beijing Co., Ltd.
- WuXi
AppTec Co., Ltd.
- Aurigene
Pharmaceutical Services Limited
- BOC
Sciences
- LGC
Bioresearch Technologies
- SPT
Labtech Ltd.
- Charles
River Laboratories International, Inc.
- Life
Chemicals Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global DNA-encoded Library Market is
expanding due to the growing adoption of precision medicine and personalized
therapeutics, which demand highly efficient and targeted drug discovery
techniques. The ability of DNA-encoded libraries to rapidly generate vast
chemical diversity and facilitate high-throughput screening accelerates the
identification of novel drug candidates tailored to specific genetic profiles.
This, coupled with increasing investments in advanced bioinformatics tools that
enhance data analysis and interpretation from DEL screenings, is driving
significant growth. The rising collaboration between pharmaceutical companies
and technology providers to integrate AI and machine learning with DEL
platforms further boosts innovation and efficiency in drug development
pipelines, contributing to market expansion.,” said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“DNA-encoded Library
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Product & Service (Kits & Reagents, Encoded Libraries,
Design & Synthesis Services, Screening Services, Others), By Therapeutic
Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological
Diseases, Autoimmune Diseases, Metabolic Diseases, Others), By Application (Hit
Generation / Identification, Hit to Lead, Hit Validation / Optimization,
Others), By End Use (Academic & Research Institutes, Pharmaceutical &
Biotechnology Companies, Contract Research Organizations, Others), By Region
and Competition, 2020-2030F”, has evaluated the future growth potential of Global
DNA-encoded Library Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global DNA-encoded
Library Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com